过去一年中添加的文章，按日期排序
ASO Author Reflections: Percutaneous Hepatic Perfusion: Past, Present, and Future
JS Zager - Annals of Surgical Oncology, 2024 - Springer
59 天前 - … Historically, systemic therapies, such as immunotherapy, have not shown much
promise… uveal melanoma in the liver—that we can harness the power of immunotherapy as well …
promise… uveal melanoma in the liver—that we can harness the power of immunotherapy as well …
[HTML][HTML] Management of acral lentiginous melanoma: current updates and future directions
MM Dugan, MC Perez, L Karapetyan… - Frontiers in Oncology, 2024 - frontiersin.org
157 天前 - … have shown promise for cutaneous melanomas, but … subtypes, especially for acral
melanoma. Overall, the unique … cutaneous melanoma, adjuvant therapy with pembrolizumab …
melanoma. Overall, the unique … cutaneous melanoma, adjuvant therapy with pembrolizumab …
[HTML][HTML] Realizing the Promise of Tumor Infiltrating Lymphocytes as a New Biomarker for Personalized Medicine May Require the Power and Precision of Artificial …
MC Montalto - AI in Precision Oncology, 2024 - liebertpub.com
254 天前 - … However, although current methods for biomarker … favorable response to
immunotherapy in melanoma. This … predictor of response to immunotherapy in several tumor types…
immunotherapy in melanoma. This … predictor of response to immunotherapy in several tumor types…
[HTML][HTML] Unraveling immunotherapy's role in propelling cancer outcomes
357 天前 - … studies that explore current obstacles and future possibilities in immunotherapy.
In … For patients with recurrent head and neck mucosal melanoma, Musha et al. examined …
In … For patients with recurrent head and neck mucosal melanoma, Musha et al. examined …